EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration

Zaw Myo Hein iD, Thazin, Suresh Kumar iD, Muhammad Danial Che Ramli iD, Che Mohd Nasril Che Mohd Nassir iD

International Journal of Molecular Sciences · 27.06.2025 · 26 (13) · 6214

DOI: 10.3390/ijms26136214 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2025. Verfasst von Zaw Myo Hein und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates. Hauptthemen laut MEDLINE: COVID-19, Neurodegenerative Diseases, Immunomodulation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ajman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic has revealed the profound and lasting impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the nervous system. Beyond acute infection, SARS-CoV-2 acts as a potent immunomodulatory agent, disrupting immune homeostasis and contributing to persistent inflammation, autoimmunity, and neurodegeneration. Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by a spectrum of neurological symptoms, including cognitive dysfunction, fatigue, neuropathy, and mood disturbances. These are linked to immune dysregulation involving cytokine imbalance, blood–brain barrier (BBB) disruption, glial activation, and T-cell exhaustion. Key biomarkers such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NFL) correlate with disease severity and chronicity. This narrative review examines the immunopathological mechanisms underpinning the neurological sequelae of long COVID, focusing on neuroinflammation, endothelial dysfunction, and molecular mimicry. We also assess the role of viral variants in shaping neuroimmune outcomes and explore emerging diagnostic and therapeutic strategies, including biomarker-guided and immune-targeted interventions. By delineating how SARS-CoV-2 reshapes neuroimmune interactions, this review aims to support the development of precision-based diagnostics and targeted therapies for long COVID-related neurological dysfunction. Emerging approaches include immune-modulatory agents (e.g., anti-IL-6), neuroprotective drugs, and strategies for repurposing antiviral or anti-inflammatory compounds in neuro-COVID. Given the high prevalence of comorbidities, personalized therapies guided by biomarkers and patient-specific immune profiles may be essential. Advancements in vaccine technologies and targeted biologics may also hold promise for prevention and disease modification. Finally, continued interdisciplinary research is needed to clarify the complex virus–immune–brain axis in long COVID and inform effective clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Neurodegenerative DiseasesImmunomodulationHumansSARS-CoV-2Blood-Brain BarrierBiomarkersPost-Acute COVID-19 Syndrome

Stichwörter der Autor:innen

COVID-19SARS-CoV-2immune systemlong COVID-19neurological disease

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, College of Medicine, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
  • Faculty of Medicine, Nursing and Health Sciences, SEGi University, Petaling Jaya 47810, Selangor, Malaysia.
  • Department of Diagnostic and Allied Health Science, Faculty Health and Life Sciences, Management and Science University, Shah Alam 40100, Selangor, Malaysia.
  • Department of Anatomy and Physiology, Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala Terengganu 20400, Terengganu, Malaysia.

ORCID-Profile: Zaw Myo Hein, Suresh Kumar, Muhammad Danial Che Ramli, Che Mohd Nasril Che Mohd Nassir

Förderung

  • Ajman University

Zitieren

APA

Hein, Z. M., Thazin, Kumar, S., Che Ramli, M. D., & Che Mohd Nassir, C. M. N. (2025). Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration. International Journal of Molecular Sciences, 26(13), 6214. https://doi.org/10.3390/ijms26136214

Vancouver

Hein ZM, Thazin, Kumar S, Che Ramli MD, Che Mohd Nassir CMN. Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration. International Journal of Molecular Sciences. 2025;26(13):6214. doi:10.3390/ijms26136214

BibTeX
@article{Hein2025,
  author = {Hein, Zaw Myo and Thazin and Kumar, Suresh and Che Ramli, Muhammad Danial and Che Mohd Nassir, Che Mohd Nasril},
  title = {Immunomodulatory Mechanisms Underlying Neurological Manifestations in Long COVID: Implications for Immune-Mediated Neurodegeneration},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {13},
  pages = {6214},
  doi = {10.3390/ijms26136214}
}
Kostenlos starten →